The global genetic testing market is set to project a CAGR of 10.25% during the forecast period, 2022-2030

The growing direct-to-consumer genetic testing, biotechnology advancements, and increasing prenatal testing drive market growth. MARKET INSIGHTS Genetic testing is used to determine a person’s vulnerability to developing specific diseases or disorders.


New York, May 17, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "GLOBAL GENETIC TESTING MARKET FORECAST 2022-2030" - https://www.reportlinker.com/p04671066/?utm_source=GNW
The major types of genetic testing include diagnostic testing, newborn screening, and prenatal testing.
Prenatal genetic testing comprises 31.2% of all genetic tests. Genetic testing can detect pre-birth diseases. It can help detect certain types of abnormalities in a baby’s genes during pregnancy. Among these, Trisomy 18 and down syndrome are often screened for as part of prenatal genetic testing. Conventionally, it is conducted through invasive testing like amniocentesis. Also, tests like cell-free DNA testing evaluate a baby’s DNA through a blood test conducted on the mother. The growth of parental genetic testing is attributed to the fears associated with developing genetic disorders in children. Such aspects contribute to the global genetic testing market growth. However, government regulations and high treatment costs hinder the market growth.

REGIONAL INSIGHTS
The global genetic testing market growth assessment includes the geographical analysis of North America, Europe, Asia-Pacific, and Rest of World.North America is the dominating region in the global market in terms of market share.

This is accredited to the well-developed healthcare infrastructure and economic growth.

COMPETITIVE INSIGHTS
With a small number of companies manufacturing complex devices, the market rivalry is intense among companies to sell products. Bio-Rad Laboratories, Abbott Laboratories, CSL Limited, BGI Group, etc., are among the leading market players.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Companies mentioned
1. 23&ME INC
2. ABBOTT LABORATORIES
3. BGI GROUP
4. BIO-RAD LABORATORIES
5. CSL LIMITED
6. DECODE GENETICS
7. ELITECH GROUP
8. EUROFINS SCIENTIFIC
9. ILLUMINA INC
10. LUMINEX CORPORATION
11. MYRIAD GENETICS INC
12. PERKINELMER INC
13. QIAGEN
14. QUEST DIAGNOSTICS INC
15. ROCHE DIAGNOSTICS INC
Read the full report: https://www.reportlinker.com/p04671066/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

 

Contact Data